These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer. Lokman NA; Ho R; Gunasegaran K; Bonner WM; Oehler MK; Ricciardelli C J Exp Clin Cancer Res; 2019 Jan; 38(1):10. PubMed ID: 30621740 [TBL] [Abstract][Full Text] [Related]
5. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer. Noye TM; Lokman NA; Oehler MK; Ricciardelli C Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma. Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166 [TBL] [Abstract][Full Text] [Related]
7. Multiple functions of S100A10, an important cancer promoter. Saiki Y; Horii A Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma. Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862 [TBL] [Abstract][Full Text] [Related]
9. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315 [TBL] [Abstract][Full Text] [Related]
10. Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients. Gong W; Liu Y; Seidl C; Dreyer T; Drecoll E; Kotzsch M; Bronger H; Dorn J; Magdolen V PLoS One; 2019; 14(2):e0212968. PubMed ID: 30811511 [TBL] [Abstract][Full Text] [Related]
11. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216 [TBL] [Abstract][Full Text] [Related]
12. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin. Wang L; Yan W; Li X; Liu Z; Tian T; Chen T; Zou L; Cui Z J Ovarian Res; 2019 Nov; 12(1):113. PubMed ID: 31739800 [TBL] [Abstract][Full Text] [Related]
13. Annexin A2 and S100A10 in the mammalian oviduct. Teijeiro JM; Roldán ML; Marini PE Cell Tissue Res; 2016 Feb; 363(2):567-77. PubMed ID: 26329302 [TBL] [Abstract][Full Text] [Related]
14. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439 [TBL] [Abstract][Full Text] [Related]
15. Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis. Dettmar L; Ahmed N; Kotzsch M; Diersch S; Napieralski R; Darmoul D; Schmitt M; Weichert W; Kiechle M; Dorn J; Magdolen V J Cancer Res Clin Oncol; 2018 Jun; 144(6):1109-1118. PubMed ID: 29546479 [TBL] [Abstract][Full Text] [Related]
16. Annexin A2-S100A10 Represents the Regulatory Component of Maxi-Cl Channel Dependent on Protein Tyrosine Dephosphorylation and Intracellular Ca²⁺. Islam MR; Okada T; Merzlyak PG; Toychiev AH; Ando-Akatsuka Y; Sabirov RZ; Okada Y Cell Physiol Biochem; 2020 May; 54(4):538-555. PubMed ID: 32442363 [TBL] [Abstract][Full Text] [Related]
17. Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells. Inokuchi J; Narula N; Yee DS; Skarecky DW; Lau A; Ornstein DK; Tyson DR Int J Cancer; 2009 Jan; 124(1):68-74. PubMed ID: 18924133 [TBL] [Abstract][Full Text] [Related]
18. Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Lokman NA; Elder AS; Ween MP; Pyragius CE; Hoffmann P; Oehler MK; Ricciardelli C Oncotarget; 2013 Aug; 4(8):1199-211. PubMed ID: 23945256 [TBL] [Abstract][Full Text] [Related]
19. N-terminal acetylation of annexin A2 is required for S100A10 binding. Nazmi AR; Ozorowski G; Pejic M; Whitelegge JP; Gerke V; Luecke H Biol Chem; 2012 Oct; 393(10):1141-50. PubMed ID: 23091277 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary. Choi CH; Sung CO; Kim HJ; Lee YY; Song SY; Song T; Kim J; Kim TJ; Lee JW; Bae DS; Kim BG Hum Pathol; 2013 Jun; 44(6):1017-23. PubMed ID: 23290009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]